Mariko Noguchi‐Sasaki

Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice

Yusuke Sasaki, Mariko Noguchi‐Sasaki, Hideyuki Yasuno et al. · International Journal of Hematology · 2012 · 49 citations

Inflammation, Hepcidin Expression, Erythropoietin Stimulation +13

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto et al. · International Journal of Hematology · 2020 · 37 citations

Thrombopoiesis, Thrombosis, Modified Thrombin Generation +15

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

Mariko Noguchi‐Sasaki, Yusuke Sasaki, Yasushi Shimonaka et al. · BMC Cancer · 2016 · 32 citations · Full text

An anti‐factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A

Masahiro Takeyama, Keiji Nogami, Tomoko Matsumoto et al. · Journal of Thrombosis and Haemostasis · 2020 · 28 citations

Inflammation, Immunohematology, Thrombosis +9

Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro

Mariko Noguchi‐Sasaki, Tetsuhiro Soeda, Atsunori Ueyama et al. · TH Open · 2018 · 23 citations · Full text

Immunohematology, Immunology, Immune System +21